The following posters were coauthored by SRI colleagues at ISPOR 17th Annual European Congress, Amsterdam:

  • Occurrence, survival and annual cost of colorectal-, breast-, prostate and lung cancer in Hungary
  • Implications of external price referencing of pharmaceuticals in Middle East Countries
  • Cost-effectiveness of the introduction of an organized adherence program for type 2 diabetes in Hungary
  • Investment aspects of generic drug policies in countries with severe resource constraints
  • Economic Evaluation of Ulipristal Acetate for the Treatment of Patients with Moderate and Severe Symptoms of Uterine Fibroids in Romania